EAM
BPMC

EFG Asset Management’s Blueprint Medicines BPMC Stock Holding History

EFG Asset Management’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-45,826
Closed -$5.88M – 169
2025
Q2 		$5.88M Sell
45,826
-27,562
-38% -$2.86M 0.83% 29
2025
Q1 		$6.5M Sell
73,388
-912
-1% -$89K 1.08% 16
2024
Q4 		$6.48M Buy
74,300
+40,611
+121% +$3.72M 0.88% 20
2024
Q3 		$3.11M Buy
33,689
+5,805
+21% +$577K 0.52% 66
2024
Q2 		$3.01M Buy
27,884
+132
+0.5% +$13.2K 0.52% 59
2024
Q1 		$2.63M Buy
27,752
+1,566
+6% +$134K 0.45% 77
2023
Q4 		$2.42M Sell
26,186
-651
-2% -$42.2K 0.46% 78
2023
Q3 		$1.35M Sell
26,837
-63,287
-70% -$3.38M 0.32% 112
2023
Q2 		$5.69M Sell
90,124
-20,017
-18% -$1.09M 1.22% 13
2023
Q1 		$4.95M Sell
110,141
-712
-0.6% -$32.1K 1.09% 26
2022
Q4 		$4.77M Sell
110,853
-4,141
-4% -$199K 1.07% 22
2022
Q3 		$7.58M Sell
114,994
-15,460
-12% -$993K 1.75% 4
2022
Q2 		$6.59M Sell
130,454
-6,237
-5% -$365K 1.39% 15
2022
Q1 		$8.73M Buy
136,691
+23,976
+21% +$1.72M 1.31% 19
2021
Q4 		$12.1M Buy
+112,715
New +$11.8M 1.58% 9

Other funds holding BPMC

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

EFG Asset Management's BPMC Position: Q3 2025 in Review

EFG Asset Management sold out of Blueprint Medicines (BPMC) in Q3 2025, closing a stake of 45,826 shares — an estimated $5.88M sold.

EFG Asset Management first reported a position in BPMC in Q4 2021 and held it in 15 quarters. The position peaked at $12.1M in Q4 2021. 5 funds tracked by Wall St. Rank hold BPMC as of Q3 2025.

  • EFG Asset Management reported no remaining Blueprint Medicines position as of Q3 2025 after selling out during the quarter.
  • EFG Asset Management sold 45,826 Blueprint Medicines shares in Q3 2025, an estimated $5.88M.
  • EFG Asset Management first reported a position in Blueprint Medicines in Q4 2021 and held it in 15 quarters.
  • EFG Asset Management's Blueprint Medicines position peaked at $12.1M in Q4 2021.
  • 5 funds tracked by Wall St. Rank held Blueprint Medicines as of Q3 2025.

Based on EFG Asset Management's 13F filing for Q3 2025, filed 3 Nov 2025.